// App-Quantinova.ai

Filters

Biomarkers











Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease











Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























1151 Abstracts

THE EFFECT OF HYDROXYCHLOROQUINE AND IRAK4 INHIBITION ON THE IFN-A AND TNF-A PRODUCTION INDUCED BY SLE RELATED IMMUNE COMPLEXES

K. Hjorton - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

DYSREGULATION OF AUTOPHAGY IN SYSTEMIC LUPUS ERYTHEMATOSUS IS CORRELATED TO TRANSCRIPTIONAL INTERFERON SIGNATURES AND PROVIDES CANDIDATE BIOMARKERS

L. Chiche - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

ANTICOAGULATION AND LONG-TERM OUTCOMES IN PATIENTS WITH RENAL ARTERY STENOSIS AND ANTIPHOSPHOLIPID SYNDROME

A. Casian - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Antiphospholipid syndrome

Hydroxychloroquine

LONG TERM USE OF HYDROXYCHLOROQUINE IN PATIENTS WITH PRIMARY ANTIPHOSPHOLIPID SYNDROME: A RETROSPECTIVE COHORT STUDY

E. Nuri - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

TWELVE MONTHS SURVIVAL RATE AND CAUSES OF WITHDRAWAL OF BELIMUMAB IN SYSTEMIC LUPUS ERYTHEMATOSUS IN A REAL LIFE SETTING

F.R. Spinelli - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

RISK FACTORS FOR ADVERSE PREGNANCY OUTCOME IN FIRST-LINE TREATED PREGNANCIES IN ANTIPHOSPHOLIPID ANTIBODIES-POSITIVE WOMEN ACCORDING TO DIFFERENT TREATMENT STRATEGIES: RESULTS FROM OUR 30 YEAR-EXPERIENCE PREGNANCY CLINIC

M.G. Lazzaroni - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Antiphospholipid syndrome

Hydroxychloroquine

ADHERENCE TO HYDROXYCHLOROQUINE AS ASSESSED BY MEASUREMENTS OF DRUG AND METABOLITE BLOOD LEVELS IN AN INTERNATIONAL PROSPECTIVE STUDY OF SLE PATIENTS IN FLARE

N. Costedoat-Chalumeau - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus nephritis

Hydroxychloroquine

HYDROXYCHLOROQUINE IMPROVES PREGNANCY OUTCOME IN WOMEN WITH ANTIPHOSPHOLIPID ANTIBODIES WITHOUT OTHER UNDERLYING CONNECTIVE TISSUE DISEASE

S. Sciascia - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Preeclampsia

Hydroxychloroquine

FACTORS THAT INFLUENCE THERAPY IN PATIENTS WITH UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE

D.P. Pena - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

Hydroxychloroquine

THE CLINICAL AND DEMOGRAPHIC FEATURES OF RELAPSING POLYCHONDRITIS: A NATIONWIDE STUDY

H. Emmungil - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Relapsing polychondritis

Hydroxychloroquine

TREATMENT OF NON-INFECTIOUS AORTITIS: STUDY OF 32 PATIENTS FROM A SINGLE CENTRE

C. Fernandez-Diaz - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Angina

Hydroxychloroquine

THE ROLE OF HYDROXYCHLOROQUINE IN ANCA POSITIVE AND NEGATIVE VASCULITIS

A. Casian - European League Against Rheumatism (EULAR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Eosinophilic granulomatosis with polyangiitis

Hydroxychloroquine

Predictors for Attaining Remission at Two Consecutive Visits in Newly Diagnosed Early RA Patients

M. Kuijper - European Workshop for Rheumatology Research (EWRR) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Hydroxychloroquine

Factors Determining Hydroxychloroquine Serum Levels in A Cohort of Chinese Patients with Systemic Lupus Erythematosus

C.C. Mok - European Workshop for Rheumatology Research (EWRR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Lupus

Hydroxychloroquine

Comparison of The Efficacy and Tolerance of The Triple Oral Therapy versus anti-TNF plus Methotrexate in Rheumatoid Arthritis with Inadequate Response To Methotrexate: A Systematic Literature Review

J. Mary - European Workshop for Rheumatology Research (EWRR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Hydroxychloroquine

Long Term Use of Hydroxychloroquine in Patients with Primary Antiphospholipid Syndrome: A Retrospective Cohort Study

E. Nuri - European Workshop for Rheumatology Research (EWRR) , 2016

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Antiphospholipid syndrome

Hydroxychloroquine

The Role of Hydroxychloroquine in ANCA Positive and Negative Vasculitis

A. Casian - European Workshop for Rheumatology Research (EWRR) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Hydroxychloroquine

Hydroxychloroquine Improves Pregnancy Outcome in Women with Antiphospholipid Antibodies without Other Underlying Connective Tissue Disease

S. Sciascia - European Workshop for Rheumatology Research (EWRR) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Hydroxychloroquine

Hydroxychloroquine Improves Pregnancy Outcome in Women with Antiphospholipid Antibodies without Other Underlying Connective Tissue Disease

S. Sciascia - European Workshop for Rheumatology Research (EWRR) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Hydroxychloroquine

Sustained Drug Free Remission in Early Ra Patients Treated To Target with Tocilizumab, Methotrexate or Their Combination

X.M. Teitsma - European Workshop for Rheumatology Research (EWRR) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Hydroxychloroquine

Copyright © 2026. QuantiNova All rights reserved